These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9552447)

  • 1. Formulation development of sustained-release hydrophilic matrix tablets of zileuton.
    Qiu Y; Hui HW; Cheskin H
    Pharm Dev Technol; 1997 Aug; 2(3):197-204. PubMed ID: 9552447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile.
    Singhvi G; Shah A; Yadav N; Saha RN
    Pharm Dev Technol; 2014 Sep; 19(6):708-16. PubMed ID: 23931031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends.
    Hamed R; AlJanabi R; Sunoqrot S; Abbas A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1330-1342. PubMed ID: 28402145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA; Femi-Oyewo MN; Odeniyi MA
    Polim Med; 2014; 44(4):209-20. PubMed ID: 25932902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of a poorly water-soluble drug in sustained-release hollow granules with a high viscosity water-soluble polymer using a fluidized bed rotor granulator.
    Asada T; Yoshihara N; Ochiai Y; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 541(1-2):246-252. PubMed ID: 29496456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
    Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
    J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of pentoxifylline from xanthan gum matrix tablets.
    El-Gazayerly ON
    Drug Dev Ind Pharm; 2003 Feb; 29(2):241-6. PubMed ID: 12648021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles.
    Park JS; Shim JY; Park JS; Choi YW; Jeong SH
    Drug Dev Ind Pharm; 2011 Jun; 37(6):664-72. PubMed ID: 21449708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on drug release from aminophylline konjac glucomannan matrix tablet].
    Zhu GQ; Zhang Y; Liu JH
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2236-9. PubMed ID: 18309662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical factors in the release of drugs from sustained release hydrophilic matrices.
    Maderuelo C; Zarzuelo A; Lanao JM
    J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FORMULATION, EVALUATION AND IN VITRO DISSOLUTION PERFORMANCE OF ENALAPRIL MALEATE SUSTAINED RELEASE MATRICES: EFFECT OF POLYMER COMPOSITION AND VISCOSITY GRADE.
    Shah A; Khan GM; Ullah H; Khan KA; Ullah K; Khan SA
    Acta Pol Pharm; 2016 Jul; 73(4):1037-1043. PubMed ID: 29648730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.